MyFinsight
Home
About
Contact
halo: the income statement
Download
Download image
Collaborative Agreements
$23,998K
Product
$94,228K
Royalty
$236,038K
Total revenues
$354,264K
(22.12%↑ Y/Y)
Investment and other
income, net
$5,333K
(-17.62%↓ Y/Y)
Operating income
$217,921K
(33.53%↑ Y/Y)
Total operating
expenses
$136,343K
(7.45%↑ Y/Y)
Income before income
tax expense
$218,958K
(32.58%↑ Y/Y)
Interest expense
$4,296K
(-5.04%↓ Y/Y)
Selling, general and
administrative
$46,088K
(11.75%↑ Y/Y)
Research and development
$17,251K
(-6.54%↓ Y/Y)
Amortization of intangibles
$17,762K
(0.00%↑ Y/Y)
Cost of sales
$55,242K
(11.77%↑ Y/Y)
Net income
$175,225K
(27.89%↑ Y/Y)
Income tax expense
$43,733K
(55.43%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)